Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kent, David G  [Clear All Filters]
2023
Sakurai M, Ishitsuka K, Ito R, Wilkinson AC, Kimura T, Mizutani E, Nishikii H, Sudo K, Becker HJiro, Takemoto H, et al. Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature. 2023.
Becker HJiro, Ishida R, Wilkinson AC, Kimura T, Lee MSue Jann, Coban C, Ota Y, Tanaka Y, Roskamp M, Sano T, et al. Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion. Cell Stem Cell. 2023.
Isobe T, Kucinski I, Barile M, Wang X, Hannah R, Bastos HP, Chabra S, Vijayabaskar MS, Sturgess KHM, Williams MJ, et al. Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes. Cell Genom. 2023;3(12):100426.
2022
Kent DG. Hematopoietic Stem cells depend on HIM and HER. Exp Hematol. 2022.
Li J, Williams MJoseph, Park HJung, Bastos HP, Wang X, Prins DPrins, Wilson NK, Johnson C, Sham K, Wantoch M, et al. STAT1 is essential for HSC function and maintains MHCIIhi stem cells that resists myeloablation and neoplastic expansion. Blood. 2022.
2021
Herd OJ, Rani GFatima, Hewitson JP, Hogg K, Stone AP, Cooper N, Kent DG, Genever PG, Hitchcock IS. Bone marrow remodelling supports hematopoiesis in response to immune thrombocytopenia progression. Blood Adv. 2021.
Oedekoven CA, Belmonte M, Bode D, Hamey FK, Shepherd MS, Che JLok Chi, Boyd G, McDonald C, Belluschi S, Diamanti E, et al. Hematopoietic stem cells retain functional potential and molecular identity in hibernation cultures. Stem Cell Reports. 2021.
2020
Kent DG, Knapp DJHF, Kannan N. Survey Says: "COVID-19 Lockdown Hits Young Faculty and Clinical Trials". Stem Cell Reports. 2020.
2018
Lyne A-M, Kent DG, Laurenti E, Cornils K, Glauche I, Perié L. A Track of the Clones: New developments in cellular barcoding. Exp Hematol. 2018.
2015
Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J, E Baxter J, Massie CE, Papaemmanuil E, Menon S, et al. Effect of Mutation Order on Myeloproliferative Neoplasms. N Engl J Med. 2015;372(7):601-612.
2014
Li J, Kent DG, Godfrey AL, Manning H, Nangalia J, Aziz A, Chen E, Saeb-Parsy K, Fink J, Sneade R, et al. JAK2V617F-homozygosity drives a phenotypic switch between myeloproliferative neoplasms in a murine model, but is insufficient to sustain clonal expansion. Blood. 2014.